Vaccines R&D Speakers



Nancy Sullivan, Ph.D.

Director, National Emerging Infectious Diseases Laboratories, Boston University


Nancy Sullivan
Denise L. Faustman, M.D., Ph.D.

Director of Immunobiology, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School

Denise L. Faustman
Ted M. Ross, Ph.D.

Director of Global Vaccine Development, Cleveland Clinic – Florida Research and Innovation Center


Ted M. Ross
Cristina Cassetti, Ph.D.

Deputy Director, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH


Cristina Cassetti
Arthur M Krieg, M.D., FACR

Founder and CEO, Zola Therapeutics; Adjunct Professor, UMass Chan Medical School RNA Therapeutics Institute

Arthur M Krieg
Michael Citron, MS

Principal Scientist, Infectious Disease and Vaccines Discovery, Merck Research Laboratories, Merck and Co., Inc.

Michael Citron
Daniel F. Hoft, M.D., Ph.D.

Director, Division of Infectious Diseases, Allergy & Immunology, Director, Center for Vaccine Development, Saint Louis University

Daniel F. Hoft
Patrick E. Duffy, M.D.

Chief, Laboratory of Malaria Immunology and Vaccinology, Chief, Vaccine Development Unit, NIAID, NIH

Patrick E. Duffy
Michael F. Good, M.D., Ph.D.

Head, Laboratory of Vaccines for the Developing World, Institute for Glycomics, Griffith University, Australia

Michael F. Good
Christopher Haqq, M.D., Ph.D.

Executive Vice President, Head of Research and Development and Chief Medical Officer, Elicio Therapeutics, Inc.

Christopher Haqq
Ronald C. Desrosiers, Ph.D.

Professor of Pathology and Laboratory Medicine, Vice Chair of Basic Research, University of Miami Miller School of Medicine

Ronald C. Desrosiers
Ritu Chakravarti, Ph.D.

Assistant Professor, The University of Toledo College of Medicine and Life Sciences

Ritu Chakravarti
Kathleen Hefferon, Ph.D.

Department of Microbiology, Cornell University

Kathleen Hefferon
Eva Lee, Ph.D.

Director and Chief Scientist at The Data and Analytics Innovation Institute

Eva Lee
Anne Wyllie, Ph.D.

Research Scientist, Epidemiology of Microbial Diseases, Yale School of Public Health

Anne Wyllie
Lauren Williamson, Ph.D.

Research Assistant Professor, Vanderbilt Vaccine Center and Scientific Programs Consultant, BigHat Biosciences

Lauren Williamson
Maya Cabot, Ph.D.

Product Manager for Virology, Integral Molecular

Maya Cabot
Ken Kato, M.D., Ph.D.

Chief, Department of Head and Neck Medical, Esophageal Oncology, National Cancer Center Hospital, Japan

Ken Kato
Hongying Duan, M.D., Ph.D.

Staff Scientist, Virology Laboratory, National Institute of Allergy and Infectious Diseases, NIH

Hongying Duan
Ozlem Equils, M.D., FAAP

President of MiOra and Senior Medical Director, Cidara Therapeutics

Ozlem Equils
Giulia Marchetti, M.D., Ph.D.

Professor, Clinic of Infectious and Tropical Diseases, Department of Health Sciences, University of Milan, Italy

Giulia Marchetti
Yariv Wine, Ph.D.

Principal Investigator, The Shumnis School of Biomedicine and Cancer Research, Faculty of Life Science, Tel Aviv University, Israel

Yariv Wine
Fan Zhang, Ph.D.

Assistant Professor of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Harvard Medical School

Fan Zhang
Courtney Finch, Ph.D.

Director of Pre-Clinical, Research & Development, Sabin Vaccine Institute

Courtney Finch
Xingmin Sun, Ph.D.

Professor, Department of Molecular Medicine, Morsani College of Medicine, University of South Florida

Xingmin Sun
Shin Nakamura, Ph.D.

Director, R&D Center, Intelligence & Technology Lab./Biomedical Institute, NPO Primate Agora, Japan

Shin Nakamura
Charles Jones, Ph.D.

Senior Director, mRNA Commercial Strategy & Innovation
Pfizer

Charles Jones
Wei Sun, Ph.D.

Professor, Immunology and Microbial Disease, Albany Medical College

Wei Sun
Kelly Sackett, Ph.D.

Senior Principal Scientist, Heightened Characterization, Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.

Kelly Sackett
Audray K. Harris, Ph.D.

Stadtman Investigator, Laboratory of Infectious Diseases, NIAID, NIH

Audray K. Harris
Rich Niemi, Ph.D.

Senior Director Business Development, hVIVO, UK

Rich Niemi
Valerie Gouon-Evans, Pharm.D., Ph.D.

Associate Professor, Department of Medicine, Center for Regenerative Medicine, Boston University

Valerie Gouon-Evans
Mark C. Poznansky, M.D., Ph.D.

Director – Vaccine and Immunotherapy Center, MGH; Professor of Medicine, Harvard Medical School

Mark C. Poznansky
Cheng Chang, Ph.D.

Associate Director, Research Lead, mRNA platform Vaccine Innovation Unit, CSL R&D

Cheng Chang
Uwe D. Staerz, M.D., Ph.D.

Chief Scientific Officer
Greffex, Inc.

Uwe D. Staerz
Walid Abdelwahab, Ph.D.

Research Assistant Professor, CTM-ART, Biomedical & Pharmaceutical Sciences, University of Montana

Walid Abdelwahab
Xiaomin Jing, Ph.D.

Principal Scientist
Pfizer

Xiaomin Jing
David Hesley, Ph.D.

Senior Scientist
Merck & Co., Inc.

David Hesley

Poster Presentations



Atsushi Kotani
Atsushi Kotani, M. Pharm

Deputy Director, Research Center, EPS Innovative Medicine (Japan) Co., Ltd./ EPS Holdings, Inc., Japan

Kazuki Tajima
Kazuki Tajima, M.MedSci.

Research Center, EPS Innovative Medicine (Japan) Co., Ltd./ EPS Holdings, Inc., Japan